-+ 0.00%
-+ 0.00%
-+ 0.00%

Azitra Expects Initial Results From ATR-COSF First-in-Human Study by Year-End

PUBT·11/10/2026 13:35:46
Listen to the news
Azitra Expects Initial Results From ATR-COSF First-in-Human Study by Year-End
  • Azitra will present ATR-COSF preclinical results at BIO-Europe in Cologne, Germany, on November 10, 2026.
  • The topical cosmetic candidate reduced visible wrinkles and improved skin elasticity in ex vivo human skin models.
  • Initial results from a first-in-human ATR-COSF study are expected by year-end.
  • The ongoing Phase 1/2 ATR-04 trial expanded in October 2026 to include additional cancer-treatment rashes and neurofibromatosis treatment-associated rashes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Azitra Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611100830PR_NEWS_USPR_____NY93869) on November 10, 2026, and is solely responsible for the information contained therein.